A number of randomized clinical trials now support the conclusion that the combined-modality regimen that includes gemcitabine (Gemzar) and cisplatin (Platinol) may improve survival in disseminated non-small-cell lung
Francesca Marrocolo, MD
Advertisement
Articles by Francesca Marrocolo, MD
Advertisement
Latest Updated Articles
- Gemcitabine and Cisplatin Combination in Early-Stage Non-Small-Cell Lung Cancer
Published: March 3rd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
FDA Approves Revumenib in R/R NPM1-Mutant AML
5
